Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of Enterobacteriaceae, Aeromonas hydrophila, and Pseudomonas maltophilia. The activities of the three drugs against other microorganisms were as follows: for staphylococci, cefamandole...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jones, R N, Fuchs, P C, Sommers, H M, Gavan, T L, Barry, A L, Gerlach, E H
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1980
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC283866/
https://ncbi.nlm.nih.gov/pubmed/6446880
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak